Advertisement
Advertisement

PRTG

PRTG logo

Portage Biotech Inc

8.17
USD
-0.87
-9.62%
Dec 18, 15:58 UTC -5
Closed
...

Portage Biotech Inc Profile

About

Portage Biotech Inc. is a clinical stage immuno-oncology company focused on overcoming immune resistance. The company source, nurture and develop therapies for a variety of cancers. Its drug development pipeline portfolio encompasses products or technologies with established scientific rationales, including intratumorals, nanoparticles, liposomes, aptamers, cell penetrating peptides, and virus-like particles. Portage Biotech Inc. is based in Tortola, British Virgin Islands.

Info & Links

CEO

Ian Walters

Headquarters

CLARENCE THOMAS BUILDING,P.O. BOX 4649, ROAD TOWN
TORTOLA, D8 VG1110, BRITISH VIRGIN ISLANDS

Industry

Biotechnology

Sector

Health Technology

Website

www.portagebiotech.com

Auditor

Marcum llp

Share holders

--

Employees

7

Portage Biotech Inc Statistics

Valuation Measures

Market Capitalization2

8.58M

Enterprise Value

5.28M

Enterprise Value/EBITDA(ttm)

-0.33

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

4.53

Price to Cash(ytd)

0.37

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-342.34%

Return on Invested Capital(ttm)

-1159.49%

Return on Assets(ttm)

-196.47%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-16.05M

Net Income Available to Common(ttm)

-71.08M

Diluted EPS(ttm)

-41.65

Share Statistics

Beta (5Y Monthly)

1.45

52-Week Change

-66.52%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

0.00

% Held by Insiders

--

% Held by Institutions

13.36%

Balance Sheet

Total Cash(mrq)

3.33M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

37.00K

Total Debt/Equity(mrq)

4.03%

Current Ratio(mrq)

3.08%

Quick Ratio(mrq)

3.08%

Book Value Per Share(mrq)

0.62

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.02

Free Cash Flow(ytd)

-3.25M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement